Statistics by Country for Vibrio parahaemolyticus


advertisement

About these extrapolations of prevalence and incidence statistics for Vibrio parahaemolyticus: These statistics are calculated extrapolations of various prevalence or incidence rates against the populations of a particular country or region. The statistics used for prevalence/incidence of Vibrio parahaemolyticus are typically based on US, UK, Canadian or Australian statistics. This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences across the various countries and regions for which the extrapolated Vibrio parahaemolyticus statistics below refer to. As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication) as to the actual prevalence or incidence of Vibrio parahaemolyticus in that region.

About prevalence and incidence statistics in general for Vibrio parahaemolyticus: The word 'prevalence' of Vibrio parahaemolyticus usually means the estimated population of people who are managing Vibrio parahaemolyticus at any given time (i.e. people with Vibrio parahaemolyticus). The term 'incidence' of Vibrio parahaemolyticus means the annual diagnosis rate, or the number of new cases of Vibrio parahaemolyticus diagnosed each year (i.e. getting Vibrio parahaemolyticus). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.



Incidence (annual) of Vibrio parahaemolyticus: 0.25 per 100,000 (DBMD 1997)
Incidence Rate for Vibrio parahaemolyticus: approx 1 in 400,000 or 0.00% or 680 people in USA [about data]
Extrapolation of Incidence Rate for Vibrio parahaemolyticus to Countries and Regions: The following table attempts to extrapolate the above incidence rate for Vibrio parahaemolyticus to the populations of various countries and regions. As discussed above, these incidence extrapolations for Vibrio parahaemolyticus are only estimates and may have limited relevance to the actual incidence of Vibrio parahaemolyticus in any region:

Country/Region Extrapolated Incidence Population Estimated Used
Vibrio parahaemolyticus in North America (Extrapolated Statistics)
USA 734 293,655,4051
Canada 81 32,507,8742
Vibrio parahaemolyticus in Europe (Extrapolated Statistics)
Austria 20 8,174,7622
Belgium 25 10,348,2762
Britain (United Kingdom) 150 60,270,708 for UK2
Czech Republic 3 1,0246,1782
Denmark 13 5,413,3922
Finland 13 5,214,5122
France 151 60,424,2132
Greece 26 10,647,5292
Germany 206 82,424,6092
Iceland 0 293,9662
Hungary 25 10,032,3752
Liechtenstein 0 33,4362
Ireland 9 3,969,5582
Italy 145 58,057,4772
Luxembourg 1 462,6902
Monaco 0 32,2702
Netherlands (Holland) 40 16,318,1992
Poland 96 38,626,3492
Portugal 26 10,524,1452
Spain 100 40,280,7802
Sweden 22 8,986,4002
Switzerland 18 7,450,8672
United Kingdom 150 60,270,7082
Wales 7 2,918,0002
Vibrio parahaemolyticus in the Balkans (Extrapolated Statistics)
Albania 8 3,544,8082
Bosnia and Herzegovina 1 407,6082
Croatia 11 4,496,8692
Macedonia 5 2,040,0852
Serbia and Montenegro 27 10,825,9002
Vibrio parahaemolyticus in Asia (Extrapolated Statistics)
Bangladesh 353 141,340,4762
Bhutan 5 2,185,5692
China 3,247 1,298,847,6242
East Timor 2 1,019,2522
Hong Kong s.a.r. 17 6,855,1252
India 2,662 1,065,070,6072
Indonesia 596 238,452,9522
Japan 318 127,333,0022
Laos 15 6,068,1172
Macau s.a.r. 1 445,2862
Malaysia 58 23,522,4822
Mongolia 6 2,751,3142
Philippines 215 86,241,6972
Papua New Guinea 13 5,420,2802
Vietnam 206 82,662,8002
Singapore 10 4,353,8932
Pakistan 397 159,196,3362
North Korea 56 22,697,5532
South Korea 120 48,233,7602
Sri Lanka 49 19,905,1652
Taiwan 56 22,749,8382
Thailand 162 64,865,5232
Vibrio parahaemolyticus in Eastern Europe (Extrapolated Statistics)
Azerbaijan 19 7,868,3852
Belarus 25 10,310,5202
Bulgaria 18 7,517,9732
Estonia 3 1,341,6642
Georgia 11 4,693,8922
Kazakhstan 37 15,143,7042
Latvia 5 2,306,3062
Lithuania 9 3,607,8992
Romania 55 22,355,5512
Russia 359 143,974,0592
Slovakia 13 5,423,5672
Slovenia 5 2,011,473 2
Tajikistan 17 7,011,556 2
Ukraine 119 47,732,0792
Uzbekistan 66 26,410,4162
Vibrio parahaemolyticus in Australasia and Southern Pacific (Extrapolated Statistics)
Australia 49 19,913,1442
New Zealand 9 3,993,8172
Vibrio parahaemolyticus in the Middle East (Extrapolated Statistics)
Afghanistan 71 28,513,6772
Egypt 190 76,117,4212
Gaza strip 3 1,324,9912
Iran 168 67,503,2052
Iraq 63 25,374,6912
Israel 15 6,199,0082
Jordan 14 5,611,2022
Kuwait 5 2,257,5492
Lebanon 9 3,777,2182
Libya 14 5,631,5852
Saudi Arabia 64 25,795,9382
Syria 45 18,016,8742
Turkey 172 68,893,9182
United Arab Emirates 6 2,523,9152
West Bank 5 2,311,2042
Yemen 50 20,024,8672
Vibrio parahaemolyticus in South America (Extrapolated Statistics)
Belize 0 272,9452
Brazil 460 184,101,1092
Chile 39 15,823,9572
Colombia 105 42,310,7752
Guatemala 35 14,280,5962
Mexico 262 104,959,5942
Nicaragua 13 5,359,7592
Paraguay 15 6,191,3682
Peru 68 27,544,3052
Puerto Rico 9 3,897,9602
Venezuela 62 25,017,3872
Vibrio parahaemolyticus in Africa (Extrapolated Statistics)
Angola 27 10,978,5522
Botswana 4 1,639,2312
Central African Republic 9 3,742,4822
Chad 23 9,538,5442
Congo Brazzaville 7 2,998,0402
Congo kinshasa 145 58,317,0302
Ethiopia 178 71,336,5712
Ghana 51 20,757,0322
Kenya 82 32,982,1092
Liberia 8 3,390,6352
Niger 28 11,360,5382
Nigeria 44 12,5750,3562
Rwanda 20 8,238,6732
Senegal 27 10,852,1472
Sierra leone 14 5,883,8892
Somalia 20 8,304,6012
Sudan 97 39,148,1622
South Africa 111 44,448,4702
Swaziland 2 1,169,2412
Tanzania 90 36,070,7992
Uganda 65 26,390,2582
Zambia 27 11,025,6902
Zimbabwe 9 1,2671,8602



Footnotes:
1. US Census Bureau, Population Estimates, 2004
2. US Census Bureau, International Data Base, 2004

Medical Tools & Articles:


Next articles:

Medical Articles:
 
 
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise